肾细胞癌的迷宫
The Labyrinth of Renal Cell Carcinoma.
作者信息
Manini Claudia, López José I
机构信息
Department of Pathology, San Giovanni Bosco Hospital, 10154 Turin, Italy.
Department of Pathology, Cruces University Hospital, Biocruces-Bizkaia Institute, University of the Basque Country, Plaza de Cruces s/n, 48903 Barakaldo, Bizkaia, Spain.
出版信息
Cancers (Basel). 2020 Feb 24;12(2):521. doi: 10.3390/cancers12020521.
Abstract
Renal cell carcinoma (RCC) ranks in the top-ten list of malignancies both in males and females [...].
摘要
肾细胞癌（RCC）在男性和女性恶性肿瘤排行榜中均位列前十[……]
相似文献
1
The Labyrinth of Renal Cell Carcinoma.
Cancers (Basel). 2020 Feb 24;12(2):521. doi: 10.3390/cancers12020521.
2
Distinguishing pediatric and adolescent renal cell carcinoma from other renal malignancies.
Pediatr Blood Cancer. 2017 May;64(5). doi: 10.1002/pbc.26315. Epub 2016 Nov 2.
3
Renal tubulocystic carcinoma is closely related to papillary renal cell carcinoma: implications for pathologic classification.
Am J Surg Pathol. 2009 Dec;33(12):1840-9. doi: 10.1097/PAS.0b013e3181be22d1.
4
NTP Toxicology and Carcinogenesis Studies of 1-Amino-2,4-Dibromoanthraquinone (CAS No. 81-49-2) in F344/N Rats and B6C3F1 Mice (Feed Studies).
Natl Toxicol Program Tech Rep Ser. 1996 Aug;383:1-370.
5
Diet and vitamin or mineral supplements and risk of renal cell carcinoma in Canada.
Cancer Causes Control. 2003 Oct;14(8):705-14. doi: 10.1023/a:1026310323882.
6
[Urologic malignancies in renal transplant candidates and recipients].
Prog Urol. 2016 Nov;26(15):1094-1113. doi: 10.1016/j.purol.2016.08.009. Epub 2016 Sep 21.
7
Histopathological characteristics of adult renal tumours: a preliminary report.
J Pak Med Assoc. 2011 Mar;61(3):224-8.
8
A distinctive, low-grade oncocytic fumarate hydratase-deficient renal cell carcinoma, morphologically reminiscent of succinate dehydrogenase-deficient renal cell carcinoma.
Histopathology. 2017 Jul;71(1):42-52. doi: 10.1111/his.13183. Epub 2017 Apr 12.
9
Occurrence of renal cell carcinoma and hematologic malignancies (predominantly lymphoid) in individuals and in families.
Fam Cancer. 2016 Oct;15(4):677-87. doi: 10.1007/s10689-016-9911-7.
10
Renal cell carcinoma in dialysis patients: a single center experience.
Int J Urol. 2006 Aug;13(8):1045-8. doi: 10.1111/j.1442-2042.2006.01498.x.
引用本文的文献
1
Implications of MTHFD2 expression in renal cell carcinoma aggressiveness.
PLoS One. 2024 Feb 29;19(2):e0299353. doi: 10.1371/journal.pone.0299353. eCollection 2024.
2
Pathology of Urologic Cancers.
Cancers (Basel). 2022 Aug 1;14(15):3751. doi: 10.3390/cancers14153751.
3
Misconduct in research integrity: Assessment the quality of systematic reviews in Cochrane urological cancer review group.
Turk J Urol. 2021 Sep;47(5):392-419. doi: 10.5152/tud.2021.21038.
4
High-Resolution Human Kidney Molecular Histology by Imaging Mass Spectrometry of Lipids.
Anal Chem. 2021 Jul 13;93(27):9364-9372. doi: 10.1021/acs.analchem.1c00649. Epub 2021 Jun 30.
5
Insights into Urological Cancer.
Cancers (Basel). 2021 Jan 8;13(2):204. doi: 10.3390/cancers13020204.
6
lncRNA and Mechanisms of Drug Resistance in Cancers of the Genitourinary System.
Cancers (Basel). 2020 Aug 3;12(8):2148. doi: 10.3390/cancers12082148.
7
Advancing the Science and Management of Renal Cell Carcinoma: Bridging the Divide between Academic and Community Practices.
J Clin Med. 2020 May 17;9(5):1508. doi: 10.3390/jcm9051508.
本文引用的文献
1
Loss of CDKN1A mRNA and Protein Expression Are Independent Predictors of Poor Outcome in Chromophobe Renal Cell Carcinoma Patients.
Cancers (Basel). 2020 Feb 17;12(2):465. doi: 10.3390/cancers12020465.
2
Deletion of Von Hippel-Lindau Interferes with Hyper Osmolality Induced Gene Expression and Induces an Unfavorable Gene Expression Pattern.
Cancers (Basel). 2020 Feb 12;12(2):420. doi: 10.3390/cancers12020420.
3
Sequential treatment of metastatic renal cancer in a complex evolving landscape.
Ann Transl Med. 2019 Dec;7(Suppl 8):S272. doi: 10.21037/atm.2019.12.05.
4
NK Cell-Based Immunotherapy in Renal Cell Carcinoma.
Cancers (Basel). 2020 Jan 29;12(2):316. doi: 10.3390/cancers12020316.
5
Low Dosed Curcumin Combined with Visible Light Exposure Inhibits Renal Cell Carcinoma Metastatic Behavior In Vitro.
Cancers (Basel). 2020 Jan 28;12(2):302. doi: 10.3390/cancers12020302.
6
EVI1 as a Prognostic and Predictive Biomarker of Clear Cell Renal Cell Carcinoma.
Cancers (Basel). 2020 Jan 28;12(2):300. doi: 10.3390/cancers12020300.
7
In-Depth Mapping of the Urinary -Glycoproteome: Distinct Signatures of ccRCC-related Progression.
Cancers (Basel). 2020 Jan 18;12(1):239. doi: 10.3390/cancers12010239.
8
Ex-Vivo Treatment of Tumor Tissue Slices as a Predictive Preclinical Method to Evaluate Targeted Therapies for Patients with Renal Carcinoma.
Cancers (Basel). 2020 Jan 17;12(1):232. doi: 10.3390/cancers12010232.
9
ESC, ALK, HOT and LOT: Three Letter Acronyms of Emerging Renal Entities Knocking on the Door of the WHO Classification.
Cancers (Basel). 2020 Jan 9;12(1):168. doi: 10.3390/cancers12010168.
10
The Future of Immunotherapy-Based Combination Therapy in Metastatic Renal Cell Carcinoma.
Cancers (Basel). 2020 Jan 7;12(1):143. doi: 10.3390/cancers12010143.
Zotero 插件